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Abstract  
Physalis angulata is a specie of the Solanaceae family, which edible fruit is used in several countries of tropical and subtropical regions of the world as 
medicinal and fruit-tree. This review shows research over the last 30 years, about traditional uses, chemical constituents and pharmacology of this specie. The 
studies related to traditional uses show that P. angulata is known for its antimalarial, anti-inflammatory and post-partum treating properties. It presents the 
different pharmacological experiments in vitro and in vivo models that have been made, also the identification of phytochemical constituents with medicinal 
importance, the main being physalins and withanolides. Pharmacological studies have shown antiparasitic, anti-inflammatory, antimicrobial, antinociceptive, 
antimalarial, antileishmanial, immunosuppressive, antiasthmatic diuretic, and antitumor activities, thus validating its traditional uses and demonstrating the 
great potential of this specie for further development within the pharmaceutical industry. 
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Resumen 
Physalis angulata, es una especie de la familia Solanaceae, de frutos comestibles, que en diferentes países de regiones tropicales y subtropicales del mundo 
utilizan como medicinal y frutal. La presente revisión muestra las investigaciones realizadas durante los últimos 30 años, sobre los usos tradicionales, 
componentes químicos y farmacología de esta especie. Los estudios referidos a los usos tradicionales, muestran que la especie es conocida por propiedades 
antimaláricas, antiinflamatorias y en el tratamiento de postparto. Se muestran los diferentes experimentos farmacológicos de ensayos in vitro  y modelos in 
vivo que se han realizado, asimismo la identificación de sus constituyentes fitoquímicos con importancia medicinal, siendo los principales las fisalinas y los 
witanólidos. Los estudios farmacológicos revelan que tiene actividad antiparasitaria, antiinflamatoria, antimicrobiana, antinociceptiva, antimalárica, 
antileishmania, inmunosupresor, antiasmático, diurético  y antitumoral, validando de esta manera sus usos tradicionales y demostrando el gran potencial que 
tiene esta especie para un mayor desarrollo dentro de la industria farmacéutica.  
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INTRODUCTION 
Physalis is an important genus of the Solanaceae 
family. Most of the species are herbaceous annuals or 
perennials, native tropical North and South America. 
Some species have edible fruits and tea make from its 
roots is considered within popular medicine. The 
medicinal uses of Physalis are numerous: a wide 
variety of species are used for asthma, urinary 
problems, rheumatism, and tumors. Their anti-
inflammatory and anti spasmodic properties are also 
known (Silva et al., 2005). Also some species of 
Physalis are used in local crafts, ornamental and food, 
the most common and most important use is in the 
preparation of sauces (Sánchez et al., 2008). 
Physalis angulata L., known in the Peruvian 
Amazon as bolsa mucalla or mullaca, is a much 
branched annual shrub, perennial in subtropical zones, 
and can grow until it reaches 1.0 m. The flowers are 
bell-shaped, but the most distinctive feature is the 
fruiting calyx which enlarges to cover the fruit and 
hangs downwards like a lantern. Each fruit is like a 
yellow pearl in to a small lantern shape pod and very 
delicious to eat. In Peru it is widely distributed within 
following departments: Amazonas, Cajamarca, 
Huánuco, Junín, La Libertad, Loreto, Madre de Dios, 
Pasco, San Martin and Ucayali (Mejía and Rengifo, 
2000). 
This review evidence the great interest about 
this plant. Therefore, the objective of this review was 
to get updated comprehensive information about P. 
angulata including their deferments uses in traditional 
medicine, phytochemistry and pharmacology. It 
performed an articles selection of last thirty years with 
the purpose of find best information about this species, 
by systematic review in following bibliographic 
databases: Science Direct, EBSCO, WILEY, PubMed, 
Open Access Journals DOAJ, Scientific Electronic 
Library Online (SCIELO), Springer Link and RSC 
Journals. 
 
Use in Traditional Medicine 
Recent ethnopharmacological studies show that 
Physalis angulata is used in many parts of the world to 
treat several diseases, as anticancer, antibacterial, for 
diabetes, treatment of malaria, anemia and reducing 
fever. In Peru, it has been documented that native 
groups in the Peruvian Amazon, use the decoction of 
leaves and fruit for “Tertian” due to postpartum 
infections (Jovel et al., 1996) and  maceration of aerial 
part for the treatment of malaria (Ruiz et al., 2011). 
Also, mestizo populations use it for treatment of 
diabetes, by taking a glass of macerated root combined 
with honey, twice daily for 60 days. The root infusion 
is taken for hepatitis; the leaf infusion is used as a 
diuretic, for asthma, malaria, inflammation and as a 
disinfectant, the unripe fruit is used to treat scabies 
(Mejía and Rengifo, 2000). 
In Brazil, the sap is used for earache, the roots 
boiled with the genus Bixa and Euterpe for jaundice 
(Duke and Vásquez, 1994). In the state of Paraíba, 
people use the leaves infusion as a sedative and 
against inflammations of bladder, spleen and kidney; 
in the case of inflammations a tea is taken until 
symptoms disappear and as sedative it is drunk at 
night (Agra et al., 2007). In Marudá community, state 
of Pará, root is taken as a tea for hepatitis symptoms, 
anemia, urine infection, stomachache, prostate and 
kidney stones (Coelho-Ferreira, 2009). In Bolivia, the 
indigenous community of Tacana, the root decoction is 
used to treat fever (Bourdy et al., 2000). 
In Nigeria the traditional use reported is broad, 
wherein all parts of the plant have been used for 
medicinal purposes; entire plant is for childbirth, 
diuretic, fever, gonorrhea, jaundice, liver diseases, 
malaria, nephritis, postpartum hemorrhage, rashes, 
skin sores, sleeping sickness, to prevent abortion, 
tumors. The fruits are recommended for infection, 
infertility, inflammation, postpartum infection, skin 
diseases. The leaves are also used for asthma, 
dermatitis, diuretic, earache, fever, gonorrhea, 
hemorrhage, hepatitis, infections, inflammation, liver 
disorders, malaria, postpartum infection, rheumatism, 
skin diseases, to prevent abortion, worms 
(schistosomiasis). The root is used for diabetes, 
earache, fever, hepatitis, jaundice, liver disorders, 
malaria and rheumatism (Lawal et al., 2010).In Kenya 
the infusion of the whole plant is used for worms and 
stomach pain (Geissler et al., 2002). 
In Samoa, the leaves are used as antibacterial 
(Cox, 1993). In the Kingdom of Tonga, the crushed 
leaves are topically applied for skin inflammation 
(Whistler, 1991). In Indonesia use the root decoction 
as a remedy for postpartum, muscle aches and 
hepatitis (Roosita et al., 2008). In India, leaf paste is 
used as an external application for wounds (Sudhakar 
et al., 2009). 
Besides medicinal uses, in Mexico the fruits 
are used to make sauces commonly accompanied by 
other plants species such as onion (Allium cepa L.) and 
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peppers (Capsicum sp.) of various kinds (Santiaguillo 
and Blas, 2009).  
Summary of use P. angulata in traditional medicine is 
presented in Table 1. 
 
Table 1 
Use in traditional medicine of Physalis angulata 
 
Country Part(s) used Ethno medicinal uses Preparation(s) Reference(s) 
Peru 
Loreto, Ucayali, San 
Martin, Madre de 
Dios 
 
Bolivia 
 
Brazil 
 
 
 
 
Indonesia 
 
 
 
India 
 
 
Nigeria  
 
 
 
 
 
 
 
Ivory Coast 
 
Kingdom of Tonga 
 
Kenya  
 
Equatorial Guinea 
Leaves, fruits, roots 
 
 
 
 
Roots 
 
Roots 
 
 
 
 
Roots 
 
 
 
Leaf 
 
 
Whole plant 
 
 
 
 
 
 
 
Whole plant 
 
Leaves 
 
Whole plant 
 
Leaf 
Postpartum infections, 
diuretic, asthma, 
malaria, inflammations, 
scabies 
 
Fever 
 
Inflammations, 
hepatitis, anemia, urine 
infection, diabetes, 
prostate, earache 
 
Remedy for 
postpartum, muscle 
aches, hepatitis 
 
Wounds 
 
 
Childbirth, diuretic, 
fever, gonorrhea, 
jaundice, liver diseases, 
malaria, nephritis, 
postpartum 
hemorrhage, rashes, 
tumours, diabetes 
 
Malaria 
 
Skin inflammation 
 
Worms, stomach ache  
 
Anti-dermatitis 
Maceration, infusion, 
decoction, direct 
application 
 
 
Decoction 
 
Infusion, tea, sap 
 
 
 
 
Decoction 
 
 
 
Paste used as a 
external application 
 
Infusion, decoction 
 
 
 
 
 
 
 
Decoction 
 
Applied topically  
 
Infusion 
 
Enema 
Jovel et al., 1996; 
Pérez, 2002; Ruiz et 
al., 2011; Mejía and 
Rengifo, 2000. 
 
Bourdy et al., 2000. 
 
Agra et al., 2007; 
Coelho-Ferreira, 
2009; Duke and 
Vásquez, 1994. 
 
Roosita et al., 2008. 
 
 
 
Sudhakar et al., 
2009. 
 
Lawal et al., 2010. 
 
 
 
 
 
 
 
Guédé et al., 2010. 
 
Whistler, 1991. 
 
Geissler et al., 2002. 
 
Akendengué, 1992. 
 
CHEMICAL CONSTITUENTS 
Phytochemical studies on P. angulata revealed that it 
contained flavonoids, alkaloids and many different 
types of plant steroids. The main components are 
commented below. 
 
Physalins 
Physalins are the steroidal lactone constituents from 
Physalis and other closely related genera, belonging to 
the family Solanaceae. The physalins are 
biogenetically related to the withanolides (Chen et al., 
2011). From the stems and leaves of P. angulata, the 
isolation of five new physalins E, F, H, I and K, along 
with physalins B, G and D is reported by Row et al. 
(1978, 1980). Two new physalins, physalins U and V, 
together with seven know ergostane-type steroidal 
compounds were isolated from methanol extract of P. 
angulata (Kuo et al., 2006). Damu et al. (2007) 
reported the isolation of a new minor physalin, 
physalin W.  
 
Withanolides 
The withanolides are a group of naturally occurring 
steroids built on an ergostane skeleton, in which C-22 
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and C-26 are appropriately oxidized in order to form a 
-lactone ring. These compounds are specific for the 
Solanaceae family, and, in particular, for the genera 
Withania, Acnistus, Dunalia, Physalis, Datura, 
Lycium and Jaborosa. So far, notable activities were 
reported for withanolides, including anticancer, 
anticonvulsive, immunosuppressive, and antioxidant 
properties (Glotter, 1991). 
Four new withanolides, physagulin A, B, C 
and D, were obtained from the methanolic extract of 
the fresh leaves and stems of P. angulata (Shingu et 
al., 1991; 1992). 
Trypanocidal activity-guided fractionation of 
MeOH extract from aerial parts of P. angulata resulted 
in isolation of ten withanolides, physagulins A, B, C, 
and F, withangulatin A, whitaminimin and four new 
physagulins H, I, J and K (Nagafuji et al., 2004). 
A study of the methanol extract from aerial 
part of P. angulata resulted in isolation of new 
withanolides, designated physalin L, M and N (Abe et 
al., 2006). 
Also He et al. (2007) reported isolation and 
structure elucidation of eleven withanolides of MeOH 
extract from aerial parts of P. angulata, four new 
compounds, physagulins L, M, N and O; and seven 
known withanolides identified as withangulatin A, 
physagulin K, withaminimin, physagulin J, physagulin 
B, pubesenolide and physagulin D. Although repeat 
names for physagulins L, N and M, they have different 
chemical structures. 
The cytotoxic assay guided fractionation of 
methanol extract P. angulata resulted in isolation a 
novel withaniloide, physanolide A, with an 
unprecedented skeleton (Kuo et al., 2006). 
Fractionation of CHCl3 and n-BuOH soluble 
of MeOH extract from the whole plant was guided by 
in vitro cytotoxic activity assay using cultured HONE-
1 and NUGC cells led to isolation of seven new 
withanolides, withangulatins B, C, D, E, F, G and H 
(Damu et al., 2007). Lee et al. (2008) reported 
isolation and structural elucidation of minor 
withanolides, withangulatin I from P. angulata. 
Jin et al. (2012) reported the discovery of 
three antiproliferative withanolides with an unusual 
carbon framework, namely, physangulidines A, B and 
C, isolates from P. angulata L. using bioassay-directed 
isolation technique. 
 
Carotenoids  
A positive correlation has been observed between 
ingestion of vegetables and fruits containing 
carotenoids and prevention of several chronic-
degenerative diseases, such as cancer, inflammation, 
cardiovascular disease, cataract and age-related 
macular degeneration. Carotenoids from fruit of P. 
angulata were determined by HPLC-PDA-MS/MS 
and 22 compounds have been identified. all-trans- -
carotene was major carotenoid, contributing 62.2% to 
total carotenoid, followed by 9-cis- -carotene and all-
trans- -cryptoxanthin, contributing around 2.9 and 
2.7%, respectively (De Rosso and Mercadante, 2007). 
 
The chemical structures, pharmacological 
activities and bibliographic references are show in 
Table 2. 
Table 2 
Chemical structure of the main constituents of Physalis angulata 
 
Structure Plant part 
(Bibliographic reference) 
Activities 
Physalins   
 
Physalin F 
 
 
 
 
 
 
 
Leaves (Row et al., 1978) 
 
Antitumour effect in vivo against 
P388 lymphocytic leukemia in 
mice (Chiang et al., 1992), 
antimalarial activity (Sá et al., 
2011), immunosuppressive 
activity (Brustolim et al., 2010; 
Soares et al., 2006), 
antileishmanial activity against 
L. amazonensis (Guimarães et 
al., 2010), cytotoxity against 
human renal cancer cells (Wu et 
al., 2012). 
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Physalin B 
 
 
 
 
Leaves (Row et al., 1978) 
 
Anti-melanoma effect (Hsu et 
al., 2012), antileishmanial 
activity against L. amazonensis 
(Guimarães et al., 2010), 
antitumour activity (Ferreira et 
al., 2006), antimalarial activity 
(Sá et al., 2011), anti-
inflammatory effect (Vieira et 
al., 2005). 
 
Physalin D 
 
 
 
 
 
Leaves (Row et al., 1980) 
 
 
 
Antitumour activity (Ferreira et 
al., 2006), antimicrobial activity 
against Gram-positive bacteria 
(Helvaci et al., 2010). 
 
 
Physalin G 
 
 
 
 
Leaves (Row et al., 1980) 
 
 
 
Antimalarial activity (Sá et al., 
2011), antileishmanial activity 
against L. amazonensis 
(Guimarães et al., 2010). 
 
 
Physalin E 
 
 
 
Leaves (Row et al., 1978) 
 
 
 
 
Anti-inflammatory effect (Pinto 
et al., 2010). 
 
 
Physalin H 
 
 
 
 
Leaves (Row et al., 1978) 
 
 
 
Immunosuppressive activity on 
T cells activation and 
proliferation both in vitro and in 
vivo (Yu et al., 2010). 
 
 
Physalin I 
 
 
 
 
Leaves (Row et al., 1980) 
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Physalin U 
 
 
 
Whole plant (Kuo et al., 2006) 
 
 
 
Weak cytotoxicity against 
different cell lines (Damu et al., 
2007). 
 
 
Physalin W 
 
 
 
Whole plant (Kuo et al., 2006) 
 
 
   
Whithanolides   
 
Withangulatin A 
 
 
 
 
Whole herb (Chen et al., 1990) 
 
Anticancer against the HCT-116 
cell line (He et al., 2007), 
trypanocidal activity against 
epimastigotes and 
trypomastigotes of T. cruzi in 
vitro (Nagafuji et al., 2004), 
inhibitory activities against 
COLO 205 and AGS cancer 
cells (Lee et al., 2008). 
 
 
Withangulatin B 
 
 
 
 
 
Whole plant (Damu et al., 2007) 
 
 
 
 
 
Strong cytotoxic against multiple 
tumour cell lines (Damu et al., 
2007). 
 
 
Withangulatin I 
 
 
 
 
Whole plant (Lee et al., 2008) 
 
 
 
 
Inhibitory activities against 
COLO 205 and AGS cancer 
cells (Lee et al., 2008). 
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Physagulin A 
 
 
 
 
Leaves and stems (Shingu et al., 
1992) 
 
 
 
 
Trypanocidal activity against 
epimastigotes and 
trypomastigotes of T. cruzi in 
vitro (Nagafuji et al., 2004).  
 
 
Physagulin B 
 
 
 
 
Leaves and stems (Shingu et al., 
1992) 
 
 
 
Physagulin C 
 
 
 
 
Leaves and stems (Shingu et al., 
1991) 
 
 
 
 
Trypanocidal activity against 
epimastigotes and 
trypomastigotes of T. cruzi in 
vitro (Nagafuji et al., 2004).  
 
 
Physagulin D 
 
 
 
 
 
 
Leaves and stems (Shingu et al., 
1992) 
 
 
 
 
 
 
Either weak or no activity 
against different human tumour 
cell lines (Jayaprakasam et al., 
2003) 
 
 
Physagulin H 
 
 
 
 
Aerial part (Nagafuji et al., 
2004) 
 
 
 
 
Trypanocidal activity against 
epimastigotes and 
trypomastigotes of T. cruzi in 
vitro (Nagafuji et al., 2004).  
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Physagulin I 
 
 
 
 
Aerial part (Nagafuji et al., 
2004) 
 
 
 
Physagulin J 
 
 
 
 
Aerial part (Nagafuji et al., 
2004) 
 
 
 
Physanolide A 
 
 
 
Whole plant (Kuo et al., 2006) 
 
 
Carotenoids   
 
all-trans- -carotene 
 
Fruits (De Rosso and 
Mercadante, 2007) 
 
 
Others   
Glc - Rha
2 1
 
Myricetin 3-O-neohesperidoside 
 
 
 
Leaves (Ismail and Alam, 2001) 
 
 
 
Strong cytotoxicity agains three 
cell lines (P-388, KB-16 and A-
549) (Ismail and Alam, 2001). 
 
 
Oleanolic Acid 
 
 
 
Leaves (Shim et al., 2002) 
 
 
 
Antibacterial activity against 
Streptococcus mutans and 
Porphyromonas gingivalis 
(Shim et al., 2002) 
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Phygrine 
 
Roots and aerial parts (Basey et 
al., 1992) 
 
   
 
Other  
A flavonol glycoside, myricetin 3-O-neohesperidoside 
was isolated from cytotoxic MeOH extract of leaves P. 
angulata (Ismail and Alam, 2001). In study realized by 
Shim et al. (2002) isolated and identified oleanolic 
acid from P. angulata, showing antibacterial activity 
against oral pathogens. Phygrine is an alkaloid that is 
present in Physalis species, including P. angulata 
(Basey et al., 1992). 
 
BIOLOGICAL ACTIVITY 
The uses of natural products to treat variety of diseases 
have increased due to large number of medicinal 
plants that have shown biological activity.  
Scientific research on the medicinal properties 
of that specie began in the 90’s, with a significant rise 
in the last few years. A resume of results of researches 
carried out are presented below. 
 
Antiparasitic activity 
Schistosomiasis is debilitating chronic disease, which 
appears in every tropical country in the world, and 
affects thousands of people specially those who had 
contacts with water hosting infected mollusks: rural 
workers, children, washerwomen in areas without 
treated water supply or drains. Tests carried out over 
Biomphalaria tenagophila mortality in regards to 
different extracts of P. angulata, shown that extracts 
with ethyl acetate (LD50 = 55.3 mg/l) and acetone 
(LD50 = 178 mg/l) from entire plant presented good 
molluscicidal activity (Dos Santos et al., 2003).  
Isolated components of the aerial part of P. 
angulata showed good activity against epimastigotes 
of Trypanosoma cruzi, etiologic agent for Chagas’ 
disease, in vitro tests of cells counting Kit-8 (Nagafuji 
et al., 2004).  
Studies carried out by Freiburghaus et al. 
(1996) on in vitro antitrypanosomal activity of twenty-
four African plant species against Trypanosoma brucei 
rhodesiense, determined that highest activity was 
found in  dichloromethane stem extract of P. angulata, 
with an IC50 value of 0.1 g/ml. 
 
 
 
Anti-inflammatory activity 
Choi y Hwang (2003) have demonstrated that metanol 
extract from flowers shows anti inflammatory action 
against edema in rats paw, induced by carragenin, 
edema of ear induced by araquidonic acid and arthritis 
induced by formaldehyde and  also antiallergic 
properties against hypersensitivity reaction of contact 
type IV induced by 2.4-dinitrofluorobenzene in rats. 
It has been proved that aqueous extract from root, by 
inhibition of different ways in rats, has powerful anti 
inflammatory and immunomodulatory activity, 
interfering with ciclooxygenase way, lymphocyte 
proliferation and production of TGF-β (Bastos et al., 
2008).  
The anti-inflammatory effect of physalin E, a 
steroid isolated from P. angulata, has been evaluated 
in sharp and chronic models of dermatitis induced 
respectively by 12-O-tetradecanoyl-phorbol-13-acetate 
(PTA) and oxazolone, in rats. The good results of 
topic application of physalin E, on experimental 
dermatitis in mice ear, (significantly reduce the ear 
edema response by 33%, 38% and 39% with 0.125, 
0.25 and 0.5 mg/ear, respectively) suggests that it 
could be a powerful and effective local anti-
inflammatory drug, useful for treatment of acute peel 
and chronic inflammatory diseases (Pinto et al., 2010). 
Moreover, Brustolim et al., (2010), established 
physalin F’s effects, in a model of arthritis induced by 
collagen, where rats were treated by oral way after the 
apparition of an edema of paw. After 20 days 
treatment with physalin F, observed a significant 
reduction of edema. 
 
Antinociceptive effect  
Bastos et al. (2006) shows that aqueous extract 
obtained from roots of P. angulata, when given 
intraperitoneally or orally, produces dose-related and 
significant antinociception according to assessment of  
abdominal constrictions elicited by acetic acid, model 
used to evaluate the potential analgesic activity of 
drugs. 
 
Antimicrobial activity 
The essential oil extracted by hydro distillation of the 
aerial part and the roots, has antimicrobial properties 
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as evidenced by Osho et al. (2010), using the diffusion 
technique in agar against Bacillus subtilis (MIC50 = 
4.0 mg/ml) and Klebsiella pneumoniae (MIC50 = 4.0 
mg/ml); moreover it has antifungic activity with C. 
albicans (MIC50 = 4.0 mg/ml), C. stellatoidea (MIC50 
= 3.75 mg/ml) and C. torulopsis (MIC50 = 4.0 mg/ml), 
which are resistant to many antibiotics. Lopes et al. 
(2006) analyzed antimicrobial activity of different 
extracts of the fruit and root of P. angulata, using the 
agar diffusion method against Staphylococcus aureus 
ATCC 6538, of which the ethanol extract of the fruit 
showed better bacterial activity, showing significant 
response when compared to ampicillin, which was 
prepared in water at concentrations ranging from 0.25 
to 4090 g/ml. The extract showed an inhibition of 
11.17 mm, matching the range of linearity of curve of 
the antibiotic, which ranged from 9.60 to 20.30 mm.  
Silva et al., (2005) conducted a comparative study 
between physalin B and enriched physalin fractions 
(mixture of B, D, F and G physalins) at three different 
concentrations using the agar diffusion technique, 
against pathogenic gram positive and gram negative 
microorganisms, demonstrating that, at concentration 
of 200 g/ml, pure physalin B exhibited  85% of the 
inhibitory zone observed with the pool of physalins, at 
same concentration. The physalin pool at 200 g/ml 
yielded 100% inhibition for Staphylococcus aureus 
ATCC 29213, S. aureus ATCC 25923, S. aureus 
ATCC 6538P, and Neisseria gonorrhoeae ATCC 
49226. 
The ethanolic extract of the flowers of P. 
angulata, exhibit noticeable antibacterial activity 
against Streptococcus mutans causing dental caries at 
all concentration tested. The bactericidal test showed 
that methanol extract of P. angulata conferred fast 
killing effect against S. mutans in 2 min at 50 mg/ml 
concentration (Hwang et al., 2004). 
The ethanolic extract of the fruit of P. 
angulata show antibacterial activity against 
Staphylococcus aureus at all concentration used (100 
mg g
-1
, 125 mg g
-1
 and 150 mg g
-1
) with inhibition 
zones between 34.5 mm and 50.5 mm as compared to 
standard antibiotic (chloramphenicol) which gave a 
mean zone inhibition diameter of 79.8 mm at 100 mg 
g
-1
 concentration (Donkor et al., 2012). 
Studies undertaken by Pietro et al. (2000) on 
natural antimicrobial agents form plant extracts 
through bioassay-guide fractionation, by in vitro 
determination of minimum inhibitory concentration 
(MIC) using the microdilution method with Alamar 
blue oxidation-reduction dye, demonstrated that crude 
CHCl3 extracts from aerial parts (500 g/ml) of P. 
angulata caused total growth inhibition of 
Mycobacterium tuberculosis H37 Rv cells. Moreover, 
32 g/ml and 625 g/ml of the physalin-containing 
fractions were necessary to inhibit 100% of M. 
tuberculosis and M. avium, respectively.  Purified 
physalin B showed MIC values against M. 
tuberculosis H37 Rv strain of 32 g/ml (Januário et 
al., 2002). 
 
Antimalarial effect  
The methanol extract from leaves of P. angulata 
showed a very interesting antiplasmodial activity 
against 3D7 (chloroquine sensitive) and W2 
(chloroquine resistant) strains of Plasmodium 
falciparum (IC50 = 1.27 and 3.02 g/ml). Similar 
activity showed the chloroform extract from leaves 
with an IC50 = 1.96 and 2.00 g/ml, respectively 
(Luzakibanza et al., 2010). In other studies, the 
hydroalcoholic extract (EtOH/H2O; 70/30) from P. 
angulata showed antiplasmodial activity in vitro on 
Plasmodium falciparum chloroquine resistant strain 
(FCR-3) with an IC50 = 4.6 g/ml (Ruiz et al., 2011). 
 
Antileishmanial activity  
Guimarães et al. (2009) showed antileishmanial 
activity of stereoids purified from P. angulata. 
Whereas physalins B and F had potent antileishmanial 
activity against intracellular amastigotes of 
Leishmania amazonensis and Leishmania major. 
Topical treatment with physalin F significantly 
reduced the lesion size, parasite load and 
histopathological alterations in BALB/c mice infected 
with L. amazonensis. 
 
Immunosuppressive effect 
Soares et al. (2003) report that physalins B, F and G 
isolated from ethanolic extract of the P. angulata  have 
potent immunosuppressive activities in macrophages 
and in lipolysaccaride-induced shock. Withangulatin 
A, an active withanolides compound isolated from P. 
angulata, exhibits compelling immunosuppressive 
activity and directly induces HO-1 expression to 
restrict the T lymphocytes from over-expression and 
modulates Th1/Th2-type balance (Sun et al., 2011). 
 
Antiasthmatic activity 
Asthma is a chronic inflammatory disease of the air-
ways with a wide range of presentations. In studies 
carried out by Rathore et al. (2011), the methanolic 
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extract of P. angulata leaves was exhibit inhibition of 
histamine response on guinea pig ileum preparation; 
indicate that extract may be acting through H1 receptor 
as antagonists. Also was inhibited responses of 5-
hydroxytryptamine on rat fundus preparation, that 
indicate the antagonistic activity of extract on 
serotonergic receptor, thus showing antagonistic 
activity on both histaminergic and serotonergic 
receptors. 
 
Diuretic activity 
Diuretics are chemicals that increase the rate of urine 
formation. Methanolic leaf extract of P. angulata 
increases urine volume significantly and also 
potentiate excretion of Na+ in urine output in rats 
(Nanumala et al., 2012), the results this study provides 
a quantitative basis to explain the traditional folkloric 
use of P. angulata as a diuretic agent. 
 
Anticancer/antitumour effect  
Studies by Hseu et al. (2011) indicate that ethyl 
acetate extracts of P. angulata exerts an inhibitory 
effect on several essential steps of metastasis, 
including migration and invasion of human oral 
squamous carcinoma cells (HSC-3).  
He et al. (2007) report the cytotoxic properties 
of eleven withanolides isolates from MeOH extract of 
the aerial parts of P. angulata towards NCl-H460 
(lung) and HCT-116 (colon) cancer cells. Where 
withangulatin A exhibited the highest anticancer 
activity against the HCT-116 cell line, with an IC50 
value of 1.64 0.06 M, while physagulin B exhibited 
highest cytotoxicity towards NCl-H460 cell line, with 
an IC50 value of 0.43 0.02 M. 
Methanolic extract from leaves of P. angulata 
demonstrated significant in vitro cytotoxicity (IC50 = 
5.7 0.3 g/ml) against human cell line HL60 (acute 
promyelocytic leukemia-ATCC CCL-240) (Faria et 
al., 2006).  
Ferreira et al. (2006) evaluated the in vitro and 
in vivo antitumour activity of physalin B and physalin 
D isolated from the aerial parts of P. angulata. In 
vitro, both compounds displayed considerable 
cytotoxicity against several cancer cell lines, showing 
IC50 values in the range of 0.58 to 15.18 g/ml for 
physalin B, and 0.28 to 2.43 g/ml for physalin D. The 
antitumour activity of both compounds was confirmed 
in vivo using mice bearing sarcoma 180 tumour cells. 
Fractions obtained from methanolic extract of 
the fruit of P. angulata, showed significant inhibition 
values against mouse lymphoma (97%) and Erlich 
carcinoma strains (93%) (Ribeiro et al., 2002). 
Myricetin 3-O-neohesperidoside, a flavonol 
glycoside isolated from a cytotoxic methanolic extract 
of the leaves of P. angulata, showed remarkable 
cytotoxity in vitro against murine leukemia cell line P-
388, epidermoid carcinoma of the nasopharynx KB-16 
cells, and lung adenocarcinoma A-549 with ED50 
values of 0.048, 0.50 and 0.55 g/ml, respectively 
(Ismail and Alam, 2001). 
Hsieh et al. (2005) showed that extracts from 
P. angulata L. induced G2/M phase arrest in human 
breast cancer cells. Wu et al. (2012) reported that 
Physalin F induced cell apoptosis through the Reactive 
Oxygen Species-mediated mitochondrial pathway and 
suppressed NF-kB activation in human renal cancer 
A498 cells. 
 
TOXICOLOGY 
In acute toxicity study, methanolic extract of P. 
angulata leaves showed no mortality at 2000 mg/kg, 
so the extract are safe for in vivo studies (Rathore et 
al., 2011). Assay conducted by Bastos et al. (2006) 
demonstrated that the treatment of mice with aqueous 
extract obtained from roots of P. angulata (10-60 
mg/kg) produces no changes in behavior, such as the 
appearance of involuntary movements, piloerection, 
stimulatory or sedative effects, respiratory depression 
or other signs at 4, 24 or 48 h after administration of 
the aqueous extract. This data indicates that the 
aqueous extract of P. angulata present a low acute 
toxicity. Moreover Alves et al. (2008) demonstrated 
the genotoxic effects of aqueous extract of P. angulata 
on human lymphocytes in vitro, using the comet assay 
and the micronucleus assay in human lymphocytes 
provided by six healthy donors.  
 
CLINICAL STUDIES 
In the review of clinical studies of P. angulata, only 
one reference was found, indicating that the species is 
a component used in the formulation for the treatment 
of malaria. “Study realized for Ankrah et al. (2003) for 
determined the efficacy and safety of a decoction 
formulated (AM-1) from Jatropha curcas, Gossypium 
hirsutum, Physalis angulata and Delonix regia. AM-1 
was used to treat malaria at an herbal clinic in Ghana. 
Results this study showed progressive elimination of 
Plasmodium falciparum and P. malariae parasites 
from the peripheral blood of the patients who were 
treated with the decoction, all without apparent toxic 
effects to humans”. 
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CONCLUSIONS 
Physalis angulata has a traditional use for 26 types of 
diseases ten tropical countries. 
Most of chemicals in this species correspond 
to group withanolides and physalins isolated from the 
roots, stems and leaves. Also fruits contain 
carotenoids. 
For pharmacological activities are ten types of 
studies, eight studies of the effect 
anticancer/antitumour, followed by seven 
antimicrobial activity and other activities with lowers 
numbers. 
The pharmacological studies conducted on P. 
angulata indicate the immense potential of this plant 
in the treatment of conditions such as schistosomiasis, 
Chagas’ disease, trypanosomiasis, inflammatory 
ailments including dermatitis and arthritis, pain, 
malaria, leishmania, asthma, tuberculosis, liquid 
retention, cancer, etc.  
However, the diverse pharmacological 
activities of P. angulata extracts and isolated 
phytochemicals have only been assayed in vitro tests 
using laboratory animals, and the results obtained may 
not necessarily be portable to the situation in humans.  
For the case of the overhaul in clinical studies, are 
only have access to one publication, indicating that 
this species is potentiated, for its in malaria when 
combining with other plant species. 
While there are gaps in the studies conducted 
so far, which need to be bridged in order to exploit the 
full medicinal potential of P. angulata,  it is still very 
clear that this is a plant with tremendous widespread 
use a now  and also with extraordinary potential for 
the future.  
On the basic of the low toxicity of P. angulata 
extracts and derived phytochemicals and their use as 
nutraceutical (fruit) and medicinal (leaves, stems and 
roots) agents, backed by proven activity of both the 
traditional formulation (macerations, infusions, 
decoctions, topical applications) and their derived 
phytochemicals (withanolides, physalins, carotenoids 
and others), further research, clinical trials and product 
development can only cement this species as a very 
Important part of our biodiversity to respect and 
sustainably use for generations to come.  
It should increase the comprehensive studies 
for this species, as a source of resource to be 
transformed in diverse products, such as 
pharmaceuticals, food intake, essential oils and 
preserves. 
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